Eli Lilly and Company is spending up to $3.8 billion to buy three vaccine makers, supercharging its push into the immunology space. Lilly has agreed to acquire Curevo Vaccine, owner of a midstage ...
May 26 (UPI) --Eli Lilly announced Tuesday that it is acquiring three vaccine companies in deals totaling nearly $4 billion. Eli LIlly is acquiring Curevo Inc., LimmaTech Biologics AG and Vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results